MedTrace Logo

Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

NCT02559440 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2015-09-24

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of MF/OXY in the treatment of adenoid hypertrophy children with severe allergic rhinitis.

Conditions

  • Adenoidal Hypertrophy

Interventions

DRUG

mometasone furoate

50μg, 1 puff in each nostril every evening

DRUG

Placebo

1 puff in each nostril every evening

DRUG

Oxymetazoline + Placebo

1 puff of Oxymetazoline +1 puff of Placebo in each nostril every evening

DRUG

Placebo + placebo

1 puff of placebo +1 puff of Placebo in each nostril every evening

DRUG

mometasone furoate + Placebo

1 puff of mometasone furoate +1 puff of Placebo in each nostril every evening

DRUG

mometasone furoate + Oxymetazoline

1 puff of mometasone furoate +1 puff of Oxymetazoline in each nostril every evening

Sponsors & Collaborators

  • Guangzhou Women and Children's Medical Center

    lead OTHER

Principal Investigators

  • renzhong Luo · Guangzhou Women and Children's Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-02-28
Completion
2015-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02559440 on ClinicalTrials.gov